These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19329795)

  • 41. Clustered telomeres in phase-separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52.
    Min J; Wright WE; Shay JW
    Genes Dev; 2019 Jul; 33(13-14):814-827. PubMed ID: 31171703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
    Wu G; Jiang X; Lee WH; Chen PL
    Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On BLM helicase in recombination-mediated telomere maintenance.
    Rezazadeh S
    Mol Biol Rep; 2013 Apr; 40(4):3049-64. PubMed ID: 23268311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.
    Pan X; Drosopoulos WC; Sethi L; Madireddy A; Schildkraut CL; Zhang D
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5940-E5949. PubMed ID: 28673972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates.
    Opresko PL; Mason PA; Podell ER; Lei M; Hickson ID; Cech TR; Bohr VA
    J Biol Chem; 2005 Sep; 280(37):32069-80. PubMed ID: 16030011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins.
    Liu D; O'Connor MS; Qin J; Songyang Z
    J Biol Chem; 2004 Dec; 279(49):51338-42. PubMed ID: 15383534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication.
    Xu D; Muniandy P; Leo E; Yin J; Thangavel S; Shen X; Ii M; Agama K; Guo R; Fox D; Meetei AR; Wilson L; Nguyen H; Weng NP; Brill SJ; Li L; Vindigni A; Pommier Y; Seidman M; Wang W
    EMBO J; 2010 Sep; 29(18):3140-55. PubMed ID: 20711169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
    Grobelny JV; Godwin AK; Broccoli D
    J Cell Sci; 2000 Dec; 113 Pt 24():4577-85. PubMed ID: 11082050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells.
    Li B; Reddy S; Comai L
    Aging (Albany NY); 2011 Apr; 3(4):395-406. PubMed ID: 21512205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The BLM helicase contributes to telomere maintenance through processing of late-replicating intermediate structures.
    Barefield C; Karlseder J
    Nucleic Acids Res; 2012 Aug; 40(15):7358-67. PubMed ID: 22576367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA.
    Machwe A; Xiao L; Orren DK
    Oncogene; 2004 Jan; 23(1):149-56. PubMed ID: 14712220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
    Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
    Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
    Hsieh MH; Tsai CH; Lin CC; Li TK; Hung TW; Chang LT; Hsin LW; Teng SC
    Cell Mol Life Sci; 2015 May; 72(9):1825-37. PubMed ID: 25430478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Break-induced replication promotes fragile telomere formation.
    Yang Z; Takai KK; Lovejoy CA; de Lange T
    Genes Dev; 2020 Oct; 34(19-20):1392-1405. PubMed ID: 32883681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
    Jiang WQ; Zhong ZH; Henson JD; Reddel RR
    Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BLM and RMI1 alleviate RPA inhibition of TopoIIIα decatenase activity.
    Yang J; Bachrati CZ; Hickson ID; Brown GW
    PLoS One; 2012; 7(7):e41208. PubMed ID: 22911760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Telomeric protein TRF2 protects Holliday junctions with telomeric arms from displacement by the Werner syndrome helicase.
    Nora GJ; Buncher NA; Opresko PL
    Nucleic Acids Res; 2010 Jul; 38(12):3984-98. PubMed ID: 20215438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Control of human telomere length by TRF1 and TRF2.
    Smogorzewska A; van Steensel B; Bianchi A; Oelmann S; Schaefer MR; Schnapp G; de Lange T
    Mol Cell Biol; 2000 Mar; 20(5):1659-68. PubMed ID: 10669743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.
    Stagno D'Alcontres M; Mendez-Bermudez A; Foxon JL; Royle NJ; Salomoni P
    J Cell Biol; 2007 Dec; 179(5):855-67. PubMed ID: 18056407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Super-telomeres in transformed human fibroblasts.
    Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.